title: A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
abstract: B-chronic lymphocytic leukemia (B-CLL), the most common human leukemia, is characterized by predominantly non-dividing malignant mature CD5+ B lymphocytes with an apoptosis defect. Various microenvironmental stimuli confer a growth advantage on these leukemic cells and extend their survival in vivo. Nevertheless, when cultured in vitro, CLL B-cells rapidly die from apoptosis. Certain cytokines may extend the survival capacity of CLL B-cells in vitro and individual anti-apoptotic effects of several cytokines have been reported. The potential cumulative effect of such cytokines has not been studied. We therefore investigated the effects on CLL B-cells survival in vitro of humoral factors, polyclonal lymphocyte activators and a combination of cytokines known for their anti-apoptotic effects. Purified CLL B-cells were cultured in the presence or absence of various soluble molecules and the leukemic cell response was assessed in terms of viability. Apoptotic cell death was detected by flow cytometry using annexinV and 7-amino-actinomycin. The survival of CLL B-cells in vitro was highly variable. When tested separately, cytokines (IL-2, -6, -10, -12, -15, -21, BAFF and APRIL) improved CLL B cell survival moderately; in combination, they significantly enhanced survival of these cells, even up to 7 days of culture. We also report that humoral factors from autologous serum are important for survival of these malignant cells. Our findings support the concept that the CLL microenvironment is critical and suggest that soluble factors may contribute directly to the prolonged survival of CLL B-cells. Therefore, the combination of cytokines we describe as providing strong resistance to apoptosis in vitro might be used to improve the treatment of CLL.
authors.affiliation: EA4666, Laboratoire d'Immunologie, Université de Picardie Jules Verne, UFR de Médecine, Amiens, France. hussein.ghamlouch@hotmail.com
authors.forename: Hussein
authors.initials: H
authors.lastname: Ghamlouch
authors.forename: Hakim
authors.initials: H
authors.lastname: Ouled-Haddou
authors.forename: Gandhi
authors.initials: G
authors.lastname: Damaj
authors.forename: Bruno
authors.initials: B
authors.lastname: Royer
authors.forename: Brigitte
authors.initials: B
authors.lastname: Gubler
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Marolleau
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis / Q000187:drug effects*; D001402:B-Lymphocytes / Q000187:drug effects* / Q000473:pathology*; D002469:Cell Separation; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D016207:Cytokines; D015847:Interleukin-4; D013755:Tetradecanoylphorbol Acetate
references.citation: Am J Clin Pathol. 2001 Sep;116(3):437-43
references.pmid: 11554173
references.citation: Semin Cancer Biol. 2010 Dec;20(6):424-30
references.pmid: 20883788
references.citation: Cytokine. 2011 Nov;56(2):133-9
references.pmid: 21824785
references.citation: Leuk Lymphoma. 2003 Nov;44(11):1865-70
references.pmid: 14738137
references.citation: J Intern Med. 2008 Dec;264(6):549-62
references.pmid: 19017179
references.citation: Br J Haematol. 1996 Jan;92(1):97-103
references.pmid: 8562418
references.citation: Blood. 2008 May 15;111(10):5173-81
references.pmid: 18326821
references.citation: Blood. 2012 Jan 5;119(1):170-9
references.pmid: 22086413
references.citation: Med Oncol. 2012 Sep;29(3):2111-26
references.pmid: 22086735
references.citation: Eur J Haematol. 2003 May;70(5):290-5
references.pmid: 12694164
references.citation: Blood. 2002 Apr 15;99(8):2969-76
references.pmid: 11929788
references.citation: Leukemia. 2001 Dec;15(12):1860-7
references.pmid: 11753606
references.citation: Eur J Haematol. 2011 Sep;87(3):228-34
references.pmid: 21595749
references.citation: Bull Exp Biol Med. 2011 May;151(1):133-41
references.pmid: 22442819
references.citation: Blood. 2011 May 19;117(20):5463-72
references.pmid: 21385850
references.citation: Blood. 2005 Aug 1;106(3):1012-20
references.pmid: 15860672
references.citation: Leuk Res. 2007 Jul;31(7):899-906
references.pmid: 17241660
references.citation: Leuk Lymphoma. 2004 Dec;45(12):2365-72
references.pmid: 15621749
references.citation: Cancer Biother Radiopharm. 2002 Oct;17(5):495-9
references.pmid: 12470418
references.citation: J Clin Invest. 2005 Mar;115(3):755-64
references.pmid: 15711642
references.citation: Blood. 2011 Nov 10;118(19):5201-10
references.pmid: 21911837
references.citation: Eur J Haematol. 2010 Oct;85(4):314-20
references.pmid: 20546021
references.citation: Blood. 2000 Oct 15;96(8):2655-63
references.pmid: 11023495
references.citation: Leuk Res. 2006 Jan;30(1):24-8
references.pmid: 16039714
references.citation: Blood Cancer J. 2012 May;2(5):e73
references.pmid: 22829975
references.citation: Blood. 2001 May 1;97(9):2777-83
references.pmid: 11313271
references.citation: Ann Hematol. 2010 Nov;89(11):1125-32
references.pmid: 20544350
references.citation: Leukemia. 2009 Nov;23(11):2118-28
references.pmid: 19657365
references.citation: Blood. 1996 Apr 15;87(8):3327-35
references.pmid: 8605349
references.citation: Nat Rev Immunol. 2008 Jan;8(1):22-33
references.pmid: 18097447
references.citation: Blood. 2002 Sep 1;100(5):1795-801
references.pmid: 12176902
references.citation: Best Pract Res Clin Haematol. 2007 Sep;20(3):385-97
references.pmid: 17707828
references.citation: Blood. 2004 Jan 15;103(2):679-88
references.pmid: 14504101
references.citation: Br J Haematol. 2001 Sep;114(3):608-15
references.pmid: 11552986
references.citation: Blood. 2007 Oct 15;110(8):2811-8
references.pmid: 17638850
references.citation: Cancer Biother Radiopharm. 1998 Aug;13(4):269-74
references.pmid: 10850362
references.citation: Blood. 2008 Jan 15;111(2):517-24
references.pmid: 17938255
references.citation: Blood. 2007 Feb 15;109(4):1660-8
references.pmid: 17038534
references.citation: J Exp Med. 1992 Nov 1;176(5):1319-26
references.pmid: 1402678
references.citation: J Exp Med. 1993 Nov 1;178(5):1473-81
references.pmid: 8228801